Kezar Life Sciences Funding: $73M Raised, Series B (2017)

Kezar Life Sciences funding overview

Kezar Life Sciences is based in South San Francisco, California. Kezar Life Sciences has raised $73M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in July 2017. The round record for Kezar Life Sciences runs through 2017; nothing later has been disclosed. Investors on record include Cormorant Asset Management, Morningside Venture, Cowen Healthcare Investments, Pappas Ventures, Qiming Venture Partners, Bay City Capital and 3 others. 9 distinct backers are named across the disclosed rounds.

Kezar Life Sciences at a glance

Total raised

$73M

Latest round

Series B

Latest round date

July 2017

Headquarters

South San Francisco, California

Notable investors

Cormorant Asset Management, Morningside Venture, Cowen Healthcare Investments, Pappas Ventures, Qiming Venture Partners, Bay City Capital, EcoR1 Capital, Omega Funds

Frequently asked about Kezar Life Sciences funding

How much has Kezar Life Sciences raised?

Kezar Life Sciences has raised $73M in total disclosed funding across the rounds on record.

Who has invested in Kezar Life Sciences?

Cormorant Asset Management, Morningside Venture, Cowen Healthcare Investments, Pappas Ventures, Qiming Venture Partners, Bay City Capital are named among the investors backing Kezar Life Sciences.

What was the latest Kezar Life Sciences funding round?

The most recent disclosed round is a Series B, announced in July 2017.

Where is Kezar Life Sciences based?

Kezar Life Sciences is based in South San Francisco, California.

When did Kezar Life Sciences last raise?

The last disclosed Kezar Life Sciences round closed in July 2017 at Series B.

Round data for Kezar Life Sciences is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in South San Francisco and backer lists below.

Companies related to Kezar Life Sciences (35)

• Autolus
• Spyre Therapeutics
• Alumis
• Edgewise Therapeutics
• Talaris Therapeutics
• Aspen Neuroscience
• Axon Neurosciences
• Viela Bio
• Greenlight Biosciences
• Triveni Bio
• NiKang Therapeutics
• Enliven Therapeutics
• Supira Medical
• Aligos Therapeutics
• OnKure Therapeutics
• EpimAb Biotherapeutics
• Verve Therapeutics
• VelosBio
• Vaxcyte
• Freenome
• Verily
• ORIC Pharmaceuticals
• Angion Biomedica
• Annexon Biosciences
• Plenty
• Race
• Nkarta Therapeutics
• Glydways
• Denali Therapeutics
• Genesis Therapeutics
• NGM Bio Holdings
• Pliant Therapeutics
• Terremoto Biosciences
• Standard BioTools
• Fluidigm

Browse related funding lists (6)

• Series B stage companies
• Companies that raised 50m 100m
• Companies funded in 2017
• Companies backed by Cormorant Asset Management
• Companies backed by Cowen Healthcare Investments
• Companies backed by Qiming Venture Partners

Company funding database · Investor directory · Founder database · Mega-rounds 2026